Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > VWF(Gene name) > Human
  • Add your favorite
  • VWF (Gene name),
  • von Willebrand factor (Protein name ),  VWF_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    VWF(F8VWF);
    Protein name:
    von Willebrand factor(vWF);
    Alternative:

    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Multimeric. Interacts with F8.
    Function:
    Important in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet-surface receptor complex GPIb-IX-V. Also acts as a chaperone for coagulation factor VIII, delivering it to the site of injury, stabilizing its heterodimeric structure and protecting it from premature clearance from plasma.
    Subcellular Location:
    Secreted Secreted extracellular space extracellular matrix Localized to storage granules.
    Protein Attributes:
    Sequence length:
    2813
    Sequence:
    50:
    MIPARFAGVL | LALALILPGT | LCAEGTRGRS | STARCSLFGS | DFVNTFDGSM | 
    100:
    YSFAGYCSYL | LAGGCQKRSF | SIIGDFQNGK | RVSLSVYLGE | FFDIHLFVNG | 
    150:
    TVTQGDQRVS | MPYASKGLYL | ETEAGYYKLS | GEAYGFVARI | DGSGNFQVLL | 
    200:
    SDRYFNKTCG | LCGNFNIFAE | DDFMTQEGTL | TSDPYDFANS | WALSSGEQWC | 
    250:
    ERASPPSSSC | NISSGEMQKG | LWEQCQLLKS | TSVFARCHPL | VDPEPFVALC | 
    300:
    EKTLCECAGG | LECACPALLE | YARTCAQEGM | VLYGWTDHSA | CSPVCPAGME | 
    350:
    YRQCVSPCAR | TCQSLHINEM | CQERCVDGCS | CPEGQLLDEG | LCVESTECPC | 
    400:
    VHSGKRYPPG | TSLSRDCNTC | ICRNSQWICS | NEECPGECLV | TGQSHFKSFD | 
    450:
    NRYFTFSGIC | QYLLARDCQD | HSFSIVIETV | QCADDRDAVC | TRSVTVRLPG | 
    500:
    LHNSLVKLKH | GAGVAMDGQD | VQLPLLKGDL | RIQHTVTASV | RLSYGEDLQM | 
    550:
    DWDGRGRLLV | KLSPVYAGKT | CGLCGNYNGN | QGDDFLTPSG | LAEPRVEDFG | 
    600:
    NAWKLHGDCQ | DLQKQHSDPC | ALNPRMTRFS | EEACAVLTSP | TFEACHRAVS | 
    650:
    PLPYLRNCRY | DVCSCSDGRE | CLCGALASYA | AACAGRGVRV | AWREPGRCEL | 
    700:
    NCPKGQVYLQ | CGTPCNLTCR | SLSYPDEECN | EACLEGCFCP | PGLYMDERGD | 
    750:
    CVPKAQCPCY | YDGEIFQPED | IFSDHHTMCY | CEDGFMHCTM | SGVPGSLLPD | 
    800:
    AVLSSPLSHR | SKRSLSCRPP | MVKLVCPADN | LRAEGLECTK | TCQNYDLECM | 
    850:
    SMGCVSGCLC | PPGMVRHENR | CVALERCPCF | HQGKEYAPGE | TVKIGCNTCV | 
    900:
    CQDRKWNCTD | HVCDATCSTI | GMAHYLTFDG | LKYLFPGECQ | YVLVQDYCGS | 
    950:
    NPGTFRILVG | NKGCSHPSVK | CKKRVTILVE | GGEIELFDGE | VNVKRPMKDE | 
    1000:
    THFEVVESGR | YIILLLGKAL | SVVWDRHLSI | SVVLKQTYQE | KVCGLCGNFD | 
    1050:
    GIQNNDLTSS | NLQVEEDPVD | FGNSWKVSSQ | CADTRKVPLD | SSPATCHNNI | 
    1100:
    MKQTMVDSSC | RILTSDVFQD | CNKLVDPEPY | LDVCIYDTCS | CESIGDCACF | 
    1150:
    CDTIAAYAHV | CAQHGKVVTW | RTATLCPQSC | EERNLRENGY | ECEWRYNSCA | 
    1200:
    PACQVTCQHP | EPLACPVQCV | EGCHAHCPPG | KILDELLQTC | VDPEDCPVCE | 
    1250:
    VAGRRFASGK | KVTLNPSDPE | HCQICHCDVV | NLTCEACQEP | GGLVVPPTDA | 
    1300:
    PVSPTTLYVE | DISEPPLHDF | YCSRLLDLVF | LLDGSSRLSE | AEFEVLKAFV | 
    1350:
    VDMMERLRIS | QKWVRVAVVE | YHDGSHAYIG | LKDRKRPSEL | RRIASQVKYA | 
    1400:
    GSQVASTSEV | LKYTLFQIFS | KIDRPEASRI | TLLLMASQEP | QRMSRNFVRY | 
    1450:
    VQGLKKKKVI | VIPVGIGPHA | NLKQIRLIEK | QAPENKAFVL | SSVDELEQQR | 
    1500:
    DEIVSYLCDL | APEAPPPTLP | PDMAQVTVGP | GLLGVSTLGP | KRNSMVLDVA | 
    1550:
    FVLEGSDKIG | EADFNRSKEF | MEEVIQRMDV | GQDSIHVTVL | QYSYMVTVEY | 
    1600:
    PFSEAQSKGD | ILQRVREIRY | QGGNRTNTGL | ALRYLSDHSF | LVSQGDREQA | 
    1650:
    PNLVYMVTGN | PASDEIKRLP | GDIQVVPIGV | GPNANVQELE | RIGWPNAPIL | 
    1700:
    IQDFETLPRE | APDLVLQRCC | SGEGLQIPTL | SPAPDCSQPL | DVILLLDGSS | 
    1750:
    SFPASYFDEM | KSFAKAFISK | ANIGPRLTQV | SVLQYGSITT | IDVPWNVVPE | 
    1800:
    KAHLLSLVDV | MQREGGPSQI | GDALGFAVRY | LTSEMHGARP | GASKAVVILV | 
    1850:
    TDVSVDSVDA | AADAARSNRV | TVFPIGIGDR | YDAAQLRILA | GPAGDSNVVK | 
    1900:
    LQRIEDLPTM | VTLGNSFLHK | LCSGFVRICM | DEDGNEKRPG | DVWTLPDQCH | 
    1950:
    TVTCQPDGQT | LLKSHRVNCD | RGLRPSCPNS | QSPVKVEETC | GCRWTCPCVC | 
    2000:
    TGSSTRHIVT | FDGQNFKLTG | SCSYVLFQNK | EQDLEVILHN | GACSPGARQG | 
    2050:
    CMKSIEVKHS | ALSVELHSDM | EVTVNGRLVS | VPYVGGNMEV | NVYGAIMHEV | 
    2100:
    RFNHLGHIFT | FTPQNNEFQL | QLSPKTFASK | TYGLCGICDE | NGANDFMLRD | 
    2150:
    GTVTTDWKTL | VQEWTVQRPG | QTCQPILEEQ | CLVPDSSHCQ | VLLLPLFAEC | 
    2200:
    HKVLAPATFY | AICQQDSCHQ | EQVCEVIASY | AHLCRTNGVC | VDWRTPDFCA | 
    2250:
    MSCPPSLVYN | HCEHGCPRHC | DGNVSSCGDH | PSEGCFCPPD | KVMLEGSCVP | 
    2300:
    EEACTQCIGE | DGVQHQFLEA | WVPDHQPCQI | CTCLSGRKVN | CTTQPCPTAK | 
    2350:
    APTCGLCEVA | RLRQNADQCC | PEYECVCDPV | SCDLPPVPHC | ERGLQPTLTN | 
    2400:
    PGECRPNFTC | ACRKEECKRV | SPPSCPPHRL | PTLRKTQCCD | EYECACNCVN | 
    2450:
    STVSCPLGYL | ASTATNDCGC | TTTTCLPDKV | CVHRSTIYPV | GQFWEEGCDV | 
    2500:
    CTCTDMEDAV | MGLRVAQCSQ | KPCEDSCRSG | FTYVLHEGEC | CGRCLPSACE | 
    2550:
    VVTGSPRGDS | QSSWKSVGSQ | WASPENPCLI | NECVRVKEEV | FIQQRNVSCP | 
    2600:
    QLEVPVCPSG | FQLSCKTSAC | CPSCRCERME | ACMLNGTVIG | PGKTVMIDVC | 
    2650:
    TTCRCMVQVG | VISGFKLECR | KTTCNPCPLG | YKEENNTGEC | CGRCLPTACT | 
    2700:
    IQLRGGQIMT | LKRDETLQDG | CDTHFCKVNE | RGEYFWEKRV | TGCPPFDEHK | 
    2750:
    CLAEGGKIMK | IPGTCCDTCE | EPECNDITAR | LQYVKVGSCK | SEVEVDIHYC | 
    2800:
    QGKCASKAMY | SIDINDVQDQ | CSCCSPTRTE | PMQVALHCTN | GSVVYHEVLN | 
    2813:
    AMECKCSPRK | CSK
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    SMR:
    Pfam:
    UniGene:
    MIM:
    KEGG:
    String:
    Uniprot:
     
    FOR
    ELISA Kit for Human vWF
    Cat.:
    E0833h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human vWF
    Cat.:
    E0833r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human vWF
    Cat.:
    E0833m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human vWF
    Cat.:
    E0833p
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human vWF
    Cat.:
    E0833d
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human vWF
    Cat.:
    E0833b
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human vWF
    MSDS:
    Please sign in first.
    CLIA Kit for Human vWF
    Cat.:
    U0833r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human vWF
    Cat.:
    U0833d
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human vWF
    Cat.:
    U0833p
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human vWF
    Cat.:
    U0833m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human vWF
    Cat.:
    U0833h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human vWF
    Cat.:
    P0833Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human vWF
    Polyclonal Antibody for Human vWF
    Polyclonal Antibody for Human vWF
    Cat.:
    P0833Rb-r
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human vWF
    Cat.:
    P0833Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human vWF
    Monoclonal Antibody for Human vWF
    Monoclonal Antibody for Human vWF
    Monoclonal Antibody for Human vWF
    Monoclonal Antibody for Human vWF
    Monoclonal Antibody for Human vWF
    Monoclonal Antibody for Human vWF
    Protein for Human vWF
    Protein for Human vWF
    Protein for Human vWF
    Protein for Human vWF
    Protein for Human vWF
    Protein for Human vWF

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Nucleotide sequence of pre-pro-von Willebrand factor cDNA."
      Bonthron D. , Orr E.C. , Mitsock L.M. , Ginsburg D. , Handin R.I. , Orkin S.H.
      Nucleic Acids Res.14:7125-7128(1986) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);VARIANTS ARG-852; ALA-1381 AND HIS-1472
    2. 2.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA];VARIANTS ILE-471; ARG-852; ALA-1381 AND HIS-1472
    3. 3.
      "The finished DNA sequence of human chromosome 12."
      Scherer S.E. , Muzny D.M. , Buhay C.J. , Chen R. , Cree A. , Ding Y. , Dugan-Rocha S. , Gill R. , Gunaratne P. , Harris R.A. , Hawes A.C. , Hernandez J. , Hodgson A.V. , Hume J. , Jackson A. , Khan Z.M. , Kovar-Smith C. , Lewis L.R. , more...
      Nature440:346-351(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    4. 4.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    5. 5.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)
      tissue: Lung.
    6. 6.
      "Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit."
      Verweij C.L. , Diergaarde P.J. , Hart M. , Pannekoek H.
      EMBO J.5:1839-1847(1986) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-1400 (ISOFORM 1);VARIANTS ARG-484; ARG-852 AND ALA-1381
    7. 7.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ERRATUM
    8. 8.
      "The human von Willebrand factor gene. Structure of the 5' region."
      Bonthron D. , Orkin S.H.
      Eur. J. Biochem.171:51-57(1988) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-178
    9. 9.
      "Evolution of human von Willebrand factor: cDNA sequence polymorphisms, repeated domains, and relationship to von Willebrand antigen II."
      Shelton-Inloes B.B. , Broze G.J. Jr. , Miletich J.P. , Sadler J.E.
      Biochem. Biophys. Res. Commun.144:657-665(1987) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-120 (ISOFORM 1);PROTEIN SEQUENCE OF 23-56
      tissue: Umbilical vein endothelial cell.
    10. 10.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 764-2813;VARIANTS ARG-852 AND ALA-1381
    11. 11.
      "Cloning and characterization of two cDNAs coding for human von Willebrand factor."
      Sadler J.E. , Shelton-Inloes B.B. , Sorace J.M. , Harlan J.M. , Titani K. , Davie E.W.
      Proc. Natl. Acad. Sci. U.S.A.82:6394-6398(1985) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 744-873 AND 1289-2813 (ISOFORM 1);VARIANTS ALA-789; ARG-852 AND ALA-1381
    12. 12.
      "Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides."
      Gevaert K. , Goethals M. , Martens L. , Van Damme J. , Staes A. , Thomas G.R. , Vandekerckhove J.
      Nat. Biotechnol.21:566-569(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 764-782
      tissue: Platelet.
    13. 13.
      "cDNA sequences for human von Willebrand factor reveal five types of repeated domains and five possible protein sequence polymorphisms."
      Shelton-Inloes B.B. , Titani K. , Sadler J.E.
      Biochemistry25:3164-3171(1986) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 781-1424 (ISOFORM 1);VARIANTS ARG-852 AND ALA-1381
    14. 14.
      "Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction."
      Mancuso D.J. , Tuley E.A. , Westfield L.A. , Lester-Mancuso T.L. , Le Beau M.M. , Sorace J.M. , Sadler J.E.
      Biochemistry30:253-269(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 990-1947;VARIANTS ALA-1381 AND HIS-1472
    15. 15.
      "Activation of human platelets by the membrane-expressed A1 domain of von Willebrand factor."
      Schulte am Esch J. II , Cruz M.A. , Siegel J.B. , Anrather J. , Robson S.C.
      Blood90:4425-4437(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1236-1476 (ISOFORM 1);VARIANT ALA-1381
    16. 16.
      "Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization."
      Ginsburg D. , Handin R.I. , Bonthron D.T. , Donlon T.A. , Bruns G.A.P. , Latt S.A. , Orkin S.H.
      Science228:1401-1406(1985) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 2621-2813 (ISOFORM 1)
    17. 17.
      "Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method."
      Lynch D.C. , Zimmerman T.S. , Collins C.J. , Brown M. , Morin M.J. , Ling E.H. , Livingston D.M.
      Cell41:49-56(1985) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 2731-2813 (ISOFORM 1)
    18. 18.
      Lynch D.C.
      Submitted (1991-07) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SEQUENCE REVISION
    19. 19.
      "Construction of cDNA coding for human von Willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene."
      Verweij C.L. , de Vries C.J.M. , Distel B. , van Zonneveld A.-J. , Geurts van Kessel A. , van Mourik J.A. , Pannekoek H.
      Nucleic Acids Res.13:4699-4717(1985) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 2731-2813 (ISOFORM 1)
    20. 20.
      "Molecular cloning of the human gene for von Willebrand factor and identification of the transcription initiation site."
      Collins C.J. , Underdahl J.P. , Levene R.B. , Ravera C.P. , Morin M.J. , Dombalagian M.J. , Ricca G. , Livingston D.M. , Lynch D.C.
      Proc. Natl. Acad. Sci. U.S.A.84:4393-4397(1987) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 2731-2813
    21. 21.
      "von Willebrand factor storage and multimerization: 2 independent intracellular processes."
      Haberichter S.L. , Fahs S.A. , Montgomery R.R.
      Blood96:1808-1815(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SUBUNIT;SUBCELLULAR LOCATION
    22. 22.
      "Identification of disulfide-bridged substructures within human von Willebrand factor."
      Marti T. , Rosselet S.J. , Titani K. , Walsh K.A.
      Biochemistry26:8099-8109(1987) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: DISULFIDE BONDS
    23. 23.
      "Primary structure of a new tetraantennary glycan of the N-acetyllactosaminic type isolated from human factor VIII/von Willebrand factor."
      Samor B. , Michalski J.C. , Debray H. , Mazurier C. , Goudemand M. , van Halbeek H. , Vliegenthart J.F.G. , Montreuil J.
      Eur. J. Biochem.158:295-298(1986) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE OF CARBOHYDRATES
    24. 24.
      "The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von Willebrand factor."
      Saenko E.L. , Scandella D.
      J. Biol. Chem.272:18007-18014(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH F8
    25. 25.
      "Screening for N-glycosylated proteins by liquid chromatography mass spectrometry."
      Bunkenborg J. , Pilch B.J. , Podtelejnikov A.V. , Wisniewski J.R.
      Proteomics4:454-465(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1515
      tissue: Plasma.
    26. 26.
      "Tryptic digestion of ubiquitin standards reveals an improved strategy for identifying ubiquitinated proteins by mass spectrometry."
      Denis N.J. , Vasilescu J. , Lambert J.-P. , Smith J.C. , Figeys D.
      Proteomics7:868-874(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-1720
      tissue: Mammary cancer.
    27. 27.
      "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."
      Chen R. , Jiang X. , Sun D. , Han G. , Wang F. , Ye M. , Wang L. , Zou H.
      J. Proteome Res.8:651-661(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-2546
      tissue: Liver.
    28. 28.
      "A strategy for precise and large scale identification of core fucosylated glycoproteins."
      Jia W. , Lu Z. , Fu Y. , Wang H.P. , Wang L.H. , Chi H. , Yuan Z.F. , Zheng Z.B. , Song L.N. , Han H.H. , Liang Y.M. , Wang J.L. , Cai Y. , Zhang Y.K. , Deng Y.L. , Ying W.T. , He S.M. , Qian X.H.
      Mol. Cell. Proteomics8:913-923(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION AT ASN-1515
    29. 29.
      "Crystal structure of the von Willebrand factor A1 domain and implications for the binding of platelet glycoprotein Ib."
      Emsley J. , Cruz M. , Handin R. , Liddington R.
      J. Biol. Chem.273:10396-10401(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1261-1468
    30. 30.
      "Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding."
      Huizinga E.G. , Martijn van der Plas R. , Kroon J. , Sixma J.J. , Gros P.
      Structure5:1147-1156(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1685-1873
    31. 31.
      "The von Willebrand factor A3 domain does not contain a metal ion-dependent adhesion site motif."
      Bienkowska J. , Cruz M. , Atiemo A. , Handin R. , Liddington R.
      J. Biol. Chem.272:25162-25167(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1686-1872
    32. 32.
      "von Willebrand factor, platelets and endothelial cell interactions."
      Ruggeri Z.M.
      J. Thromb. Haemost.1:1335-1342(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW
    33. 33.
      "Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA."
      Ginsburg D. , Konkle B.A. , Gill J.C. , Montgomery R.R. , Bockenstedt P.L. , Johnson T.A. , Yang A.Y.
      Proc. Natl. Acad. Sci. U.S.A.86:3723-3727(1989) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS VWD2 TRP-1597 AND ASP-1607
    34. 34.
      "Analysis of the relationship of von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia and identification of a potential type IIA vWD mutation (IIe865 to Thr)."
      Iannuzzi M.C. , Hidaka N. , Boehnke M. , Bruck M.E. , Hanna W.T. , Collins F.S. , Ginsburg D.
      Am. J. Hum. Genet.48:757-763(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 THR-1628
    35. 35.
      "Identification of two point mutations in the von Willebrand factor gene of three families with the 'Normandy' variant of von Willebrand disease."
      Gaucher C. , Mercier B. , Jorieux S. , Oufkir D. , Mazurier C.
      Br. J. Haematol.78:506-514(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS VWD2 TRP-816 AND GLN-854
    36. 36.
      "An Arg545-->Cys545 substitution mutation of the von Willebrand factor in type IIB von Willebrand's disease."
      Donner M. , Andersson A.-M. , Kristoffersson A.-C. , Nilsson I.M. , Dahlback B. , Holmberg L.
      Eur. J. Haematol.47:342-345(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 CYS-1308
    37. 37.
      "Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences."
      Randi A.M. , Rabinowitz I. , Mancuso D.J. , Mannucci P.M. , Sadler J.E.
      J. Clin. Invest.87:1220-1226(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS VWD2 TRP-1306; CYS-1308 AND PRO-1613
    38. 38.
      "The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain."
      Cooney K.A. , Nichols W.C. , Bruck M.E. , Bahou W.F. , Shapiro A.D. , Bowie E.J.W. , Gralnick H.R. , Ginsburg D.
      J. Clin. Invest.87:1227-1233(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS VWD2 TRP-1306; CYS-1308; MET-1316 AND GLN-1341;VARIANT HIS-1399
    39. 39.
      "Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib-IX receptor."
      Ware J. , Dent J.A. , Azuma H. , Sugimoto M. , Kyrle P.A. , Yoshioka A. , Ruggeri Z.M.
      Proc. Natl. Acad. Sci. U.S.A.88:2946-2950(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 CYS-1313
    40. 40.
      "Expression of von Willebrand factor 'Normandy': an autosomal mutation that mimics hemophilia A."
      Tuley E.A. , Gaucher C. , Jorieux S. , Worrall N.K. , Sadler J.E. , Mazurier C.
      Proc. Natl. Acad. Sci. U.S.A.88:6377-6381(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 MET-791
    41. 41.
      "Germ-line mosaicism for a valine-to-methionine substitution at residue 553 in the glycoprotein Ib-binding domain of von Willebrand factor, causing type IIB von Willebrand disease."
      Murray E.W. , Giles A.R. , Lillicrap D.
      Am. J. Hum. Genet.50:199-207(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 MET-1316
    42. 42.
      "Molecular study of von Willebrand disease: identification of potential mutations in patients with type IIA and type IIB."
      Pietu G. , Ribba A.S. , de Paillette L. , Cherel G. , Lavergne J.-M. , Bahnak B.R. , Meyer D.
      Blood Coagul. Fibrinolysis3:415-421(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS VWD2 TRP-1306; MET-1316; THR-1628 AND SER-1648
    43. 43.
      "Type IIB von Willebrand's disease: gene mutations and clinical presentation in nine families from Denmark, Germany and Sweden."
      Donner M. , Kristoffersson A.-C. , Lenk H. , Scheibel E. , Dahlback B. , Nilsson I.M. , Holmberg L.
      Br. J. Haematol.82:58-65(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS VWD2 TRP-1306; CYS-1308; LEU-1314 AND LEU-1318
    44. 44.
      "Defects in type IIA von Willebrand disease: a cysteine 509 to arginine substitution in the mature von Willebrand factor disrupts a disulphide loop involved in the interaction with platelet glycoprotein Ib-IX."
      Lavergne J.-M. , de Paillette L. , Bahnak B.R. , Ribba A.-S. , Fressinaud E. , Meyer D. , Pietu G.
      Br. J. Haematol.82:66-72(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 ARG-1272
    45. 45.
      "Characterization of recombinant von Willebrand factor corresponding to mutations in type IIA and type IIB von Willebrand disease."
      Ribba A.S. , Voorberg J. , Meyer D. , Pannekoek H. , Pietu G.
      J. Biol. Chem.267:23209-23215(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 LYS-1638
    46. 46.
      "von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib."
      Rabinowitz I. , Tuley E.A. , Mancuso D.J. , Randi A.M. , Firkin B.G. , Howard M.A. , Sadler J.E.
      Proc. Natl. Acad. Sci. U.S.A.89:9846-9849(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 SER-1324
    47. 47.
      "Identification of three candidate mutations causing type IIA von Willebrand disease using a rapid, nonradioactive, allele-specific hybridization method."
      Inbal A. , Englender T. , Kornbrot N. , Randi A.M. , Castaman G. , Mannucci P.M. , Sadler J.E.
      Blood82:830-836(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS VWD2 GLN-1597; ARG-1609 AND GLU-1665
    48. 48.
      "Substitution of cysteine for phenylalanine 751 in mature von Willebrand factor is a novel candidate mutation in a family with type IIA von Willebrand disease."
      Gaucher C. , Hanss M. , Dechavanne M. , Mazurier C.
      Br. J. Haematol.83:94-99(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 CYS-1514
    49. 49.
      "Two new candidate mutations in type IIA von Willebrand's disease (Arg834-->Gly, Gly846-->Arg) and one polymorphism (Tyr821-->Cys) in the A2 region of the von Willebrand factor."
      Donner M. , Kristoffersson A.C. , Berntorp E. , Scheibel E. , Thorsen S. , Dahlback B. , Nilsson I.M. , Holmberg L.
      Eur. J. Haematol.51:38-44(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS VWD2 GLY-1597 AND ARG-1609;VARIANT CYS-1584
    50. 50.
      "Type IIB mutation His-505-->Asp implicates a new segment in the control of von Willebrand factor binding to platelet glycoprotein Ib."
      Rabinowitz I. , Randi A.M. , Shindler K.S. , Tuley E.A. , Rustagi P.K. , Sadler J.E.
      J. Biol. Chem.268:20497-20501(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 ASP-1268
    51. 51.
      "von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure."
      Holmberg L. , Dent J.A. , Schneppenheim R. , Budde U. , Ware J. , Ruggeri Z.M.
      J. Clin. Invest.91:2169-2177(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 LEU-1266
    52. 52.
      "Leu 697-->Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease."
      Hilbert L. , Gaucher C. , de Romeuf C. , Horellou M.H. , Vink T. , Mazurier C.
      Blood83:1542-1550(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 VAL-1460
    53. 53.
      "Characterization of Leu777Pro and Ile865Thr type IIA von Willebrand disease mutations."
      Lyons S.E. , Cooney K.A. , Bockenstedt P. , Ginsburg D.
      Blood83:1551-1557(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS VWD2 PRO-1540 AND THR-1628
    54. 54.
      "Characterization of the von Willebrand factor gene (VWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish origin."
      Zhang Z.P. , Blombaeck M. , Egberg N. , Falk G. , Anvret M.
      Genomics21:188-193(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD3 TYR-2739
    55. 55.
      "Genetic heterogeneity of severe von Willebrand disease type III in the German population."
      Schneppenheim R. , Krey S. , Bergmann F. , Bock D. , Budde U. , Lange M. , Linde R. , Mittler U. , Meili E. , Mertes G. , Olek K. , Plendl H. , Simeoni E.
      Hum. Genet.94:640-652(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD3 CYS-377
    56. 56.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 SER-528
    57. 57.
      "Identification of two mutations (Arg611Cys and Arg611His) in the A1 loop of von Willebrand factor (vWF) responsible for type 2 von Willebrand disease with decreased platelet-dependent function of vWF."
      Hilbert L. , Gaucher C. , Mazurier C.
      Blood86:1010-1018(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS VWD2 CYS-1374 AND HIS-1374
    58. 58.
      "A novel candidate mutation (Arg611-->His) in type I 'platelet discordant' von Willebrand's disease with desmopressin-induced thrombocytopenia."
      Castaman G. , Eikenboom C.J.C. , Rodeghiero F. , Briet K. , Reitsma P.H.
      Br. J. Haematol.89:656-658(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 HIS-1374
    59. 59.
      "Effects of different amino-acid substitutions in the leucine 694-proline 708 segment of recombinant von Willebrand factor."
      Hilbert L. , Gaucher C. , Mazurier C.
      Br. J. Haematol.91:983-990(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 VAL-1461
    60. 60.
      "Identification of a candidate missense mutation in a family with von Willebrand disease type IIC."
      Schneppenheim R. , Thomas K.B. , Krey S. , Budde U. , Jessat U. , Sutor A.H. , Zeiger B.
      Hum. Genet.95:681-686(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 ARG-550
    61. 61.
      "Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease."
      Schneppenheim R. , Brassard J. , Krey S. , Budde U. , Kunicki T.J. , Holmberg L. , Ware J. , Ruggeri Z.M.
      Proc. Natl. Acad. Sci. U.S.A.93:3581-3586(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 ARG-2773
    62. 62.
      "A novel von Willebrand disease-causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion."
      Allen S. , Abuzenadah A.M. , Hinks J. , Blagg J.L. , Gursel T. , Ingerslev J. , Goodeve A.C. , Peake I.R. , Daly M.E.
      Blood96:560-568(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD1 TRP-273;VARIANT VWD3 TRP-273
    63. 63.
      "Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins."
      Bodo I. , Katsumi A. , Tuley E.A. , Eikenboom J.C. , Dong Z. , Sadler J.E.
      Blood98:2973-2979(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD1 ARG-1149;MUTAGENESIS OF CYS-1149 AND CYS-1169
    64. 64.
      "Factor VIII deficiency not induced by FVIII gene mutation in a female first cousin of two brothers with haemophilia A."
      Mazurier C. , Parquet-Gernez A. , Gaucher C. , Lavergne J.-M. , Goudemand J.
      Br. J. Haematol.119:390-392(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 ARG-1060
    65. 65.
      "The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: co-segregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype."
      Bowen D.J. , Collins P.W. , Lester W. , Cumming A.M. , Keeney S. , Grundy P. , Enayat S.M. , Bolton-Maggs P.H. , Keeling D.M. , Khair K. , Tait R.C. , Wilde J.T. , Pasi K.J. , Hill F.G.
      Br. J. Haematol.128:830-836(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CYS-1584
    66. 66.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT [LARGE SCALE ANALYSIS] CYS-1570
    67. 67.
      "C1272F: a novel type 2A von Willebrand's disease mutation in A1 domain; its clinical significance."
      Woods A.I. , Sanchez-Luceros A. , Kempfer A.C. , Powazniak Y. , Calderazzo Pereyra J.C. , Blanco A.N. , Meschengieser S.S. , Lazzari M.A.
      Haemophilia18:112-116(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT VWD2 PHE-1272
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Tumor necrosis Alpha Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter